De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Fisher & Paykel Healthcare Toekomstige groei

Future criteriumcontroles 5/6

Fisher & Paykel Healthcare zal naar verwachting groeien in winst en omzet met respectievelijk 24.7% en 10.8% per jaar. De winst per aandeel zal naar verwachting groeien met 24.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 23.9% zijn.

Belangrijke informatie

24.7%

Groei van de winst

24.3%

Groei van de winst per aandeel

Medical Equipment winstgroei	19.8%
Inkomstengroei	10.8%
Toekomstig rendement op eigen vermogen	23.9%
Dekking van analisten	Good
Laatst bijgewerkt	04 Oct 2024

Recente toekomstige groei-updates

Recent updates

Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Aug 21

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Jul 29

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Jul 11

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected

Jun 22

There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings

Jun 05

Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Mar 27

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Feb 22

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price

Feb 05

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate

Jan 03

We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Nov 30

Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital

Nov 12

Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Aug 28

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Aug 10

Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly

Jul 02

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

May 01

Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)

Jan 23

Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Dec 27

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Oct 28

Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value

Oct 13

Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet

Sep 28

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Jul 24

A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

Jul 10

Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly

Jun 12

A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Apr 17

Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention

Dec 26

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Dec 05

This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation

Aug 11

Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?

Aug 01

Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?

Jul 07

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Jun 24

Winst- en omzetgroeiprognoses

NZSE:FPH - Toekomstschattingen van analisten en financiële gegevens uit het verleden (NZD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
3/31/2027	2,499	521	385	621	14
3/31/2026	2,231	434	291	540	15
3/31/2025	1,988	359	314	471	15
3/31/2024	1,743	133	91	430	N/A
12/31/2023	1,719	197	61	411	N/A
9/30/2023	1,694	262	31	393	N/A
6/30/2023	1,638	256	29	316	N/A
3/31/2023	1,581	250	27	238	N/A
12/31/2022	1,527	251	6	218	N/A
9/30/2022	1,472	251	-15	199	N/A
6/30/2022	1,577	314	70	262	N/A
3/31/2022	1,682	377	155	324	N/A
12/31/2021	1,821	449	259	430	N/A
9/30/2021	1,961	521	363	535	N/A
6/30/2021	1,966	522	402	580	N/A
3/31/2021	1,971	524	441	625	N/A
12/31/2020	1,787	458	344	526	N/A
9/30/2020	1,603	392	247	426	N/A
6/30/2020	1,433	339	199	374	N/A
3/31/2020	1,264	287	151	321	N/A
12/31/2019	1,197	260	133	297	N/A
9/30/2019	1,130	233	115	273	N/A
6/30/2019	1,100	221	117	263	N/A
3/31/2019	1,070	209	120	253	N/A
12/31/2018	1,052	208	135	256	N/A
9/30/2018	1,034	206	151	259	N/A
6/30/2018	1,007	198	150	253	N/A
3/31/2018	981	190	149	248	N/A
12/31/2017	954	181	N/A	224	N/A
9/30/2017	928	172	N/A	200	N/A
6/30/2017	911	171	N/A	197	N/A
3/31/2017	894	169	N/A	194	N/A
12/31/2016	877	164	N/A	190	N/A
9/30/2016	860	160	N/A	186	N/A
6/30/2016	838	152	N/A	165	N/A
3/31/2016	815	143	N/A	145	N/A
12/31/2015	776	135	N/A	135	N/A
9/30/2015	736	126	N/A	126	N/A
6/30/2015	704	120	N/A	136	N/A
3/31/2015	672	113	N/A	147	N/A
12/31/2014	655	107	N/A	134	N/A
9/30/2014	637	101	N/A	122	N/A
6/30/2014	630	99	N/A	111	N/A
3/31/2014	623	97	N/A	100	N/A
12/31/2013	608	93	N/A	94	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei FPH ( 24.7% per jaar) ligt boven de spaarquote ( 2.8% ).

Winst versus markt: De winst van FPH ( 24.7% per jaar) zal naar verwachting sneller groeien dan de NZ markt ( 18% per jaar).

Hoge groeiwinsten: De winst van FPH zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van FPH ( 10.8% per jaar) zal naar verwachting sneller groeien dan de markt NZ ( 4.1% per jaar).

Hoge groei-inkomsten: De omzet van FPH ( 10.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen FPH zal naar verwachting over 3 jaar hoog zijn ( 23.9 %)

Fisher & Paykel Healthcare Toekomstige groei

Future criteriumcontroles 5/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 7.3% to NZ$27.77

Price target increased by 7.0% to NZ$23.63

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of 2024

Consensus EPS estimates fall by 14%

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2024

Price target increased by 7.4% to NZ$23.89

Recent updates

Insider recently sold NZ$1.3m worth of stock

MD, CEO & Executive Director recently sold NZ$1.8m worth of stock

Price target increased by 7.3% to NZ$27.77

Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Fisher & Paykel Healthcare Corporation Limited Announces Board and Committee Changes

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected

Upcoming dividend of NZ$0.28 per share

Fisher & Paykel Healthcare Corporation Limited, Annual General Meeting, Aug 28, 2024

There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings

Final dividend of NZ$0.28 announced

Full year 2024 earnings: EPS misses analyst expectations

Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Price target increased by 7.0% to NZ$23.63

Fisher & Paykel Healthcare Corporation Limited to Report Fiscal Year 2024 Results on May 29, 2024

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

First half 2024 earnings: EPS exceeds analyst expectations

We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Fisher & Paykel Healthcare Corporation Limited Approves Interim Dividend, Payable on 18 December 2023

Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital

Fisher & Paykel Healthcare Corporation Limited to Report First Half, 2024 Results on Nov 29, 2023

Fisher & Paykel Healthcare Corporation Limited Announces Launch of F&P Solo Mask in New Zealand and Australia for Treatment of Obstructive Sleep Apnea

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of 2024

Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly

Upcoming dividend of NZ$0.27 per share at 1.6% yield

Fisher & Paykel Healthcare Corporation Limited, Annual General Meeting, Aug 29, 2023

Consensus EPS estimates fall by 14%

Full year 2023 earnings released: EPS: NZ$0.43 (vs NZ$0.65 in FY 2022)

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2024

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Vice President of Products & Technology exercised options to buy NZ$194k worth of stock.

Price target increased by 7.4% to NZ$23.89

Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)

Consensus EPS estimates increase by 11%

Fisher & Paykel Healthcare Corporation Limited Provides Revenue Guidance for the Financial Year Ending 31 March 2023

Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Price target increased to NZ$22.88

Price target increased to NZ$22.79

Investor sentiment improved over the past week

First half 2023 earnings: EPS and revenues exceed analyst expectations

Fisher & Paykel Healthcare Corporation Limited Announces Ordinary Distribution for the Six Months Ended September 30, 2022, Payable on December 21, 2022

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value

Independent Non-Executive Director recently bought NZ$58k worth of stock

Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet

Independent Non-Executive Director recently bought NZ$108k worth of stock

Fisher & Paykel Healthcare Corporation Limited to Report First Half, 2023 Results on Nov 29, 2022

Price target decreased to NZ$21.30

Consensus EPS estimates fall by 29%

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of Fiscal Year 2023

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

Fisher & Paykel Healthcare Announces Management Changes

Fisher & Paykel Healthcare Corporation Limited Declares Ordinary Dividend for the Six Months Period Ended March 31, 2022, Payable on July 6, 2022

Upcoming dividend of NZ$0.26 per share

Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly

Consensus EPS estimates fall by 15%

Fisher & Paykel Healthcare Corporation Limited Appoints Cather Simpson as Non-Executive Director, Effect 1 June 2022

Price target decreased to NZ$23.98

Full year 2022 earnings: EPS in line with expectations, revenues disappoint